Our present data extend this previous work by showing that skeletal muscle expression of FoxP1 is increased in multiple models of cancer cachexia in which FoxO factors are also elevated, and by further identifying FoxP1 as a downstream target of FoxO1. This evidence concerns the gene FOXO1 and cancer.